BusinessBeyondSpring Chief Medical Officer to Present Clinical Data for Lead Asset Plinabulin for Non-Small Cell Lung Cancer Treatment and Neutropenia Prevention at 2017 BIO Asia International Conference in TokyoBy Nasdaq OMXMar 14, 2017, 12:31 PM UTC
